3rd Quarter - Report

TCH GROUP, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC )

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Extension of the U.S. R&D tax credit including all such provisions in HR 422 "To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit. International tax treaties and the ratification of the Second Protocol to the Income Tax Treaty between the U.S. and France.

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 422 (111th)

Copyright/Patent/Trademark CPT

All provisions of S369 "Protecting Access to Affordable Generic Drugs Act of 2009"; and HR 1706 "Protecting Consumer Access to Generic Drugs Act of 2009"; all provisions of S515 "The Patent Reform Act of 2009" and HR 1260 "The Patent Refrom Act of 2009"

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1260 (111th), H.R. 1706 (111th)

Health Issues HCR

HR3200 "America's Affordable Health Choices Act"; and S1769 "Affordable Health Choices Act"; General issues related to the Medicare Part D program and issues related to awareness of atrial fibrillation and access to treatment.; All provisions of HR2502 "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes"; All provisions of H. Res. 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month"

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2502 (111th), H.R. 3200 (111th), H.Res. 231 (111th)

Medicare/Medicaid MMM

Issues related to the Medicaid Program Medicare Part B Reimbursement

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.